BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34360833)

  • 1. CD39 Regulation and Functions in T Cells.
    Timperi E; Barnaba V
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
    Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
    Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.
    Perrot I; Michaud HA; Giraudon-Paoli M; Augier S; Docquier A; Gros L; Courtois R; Déjou C; Jecko D; Becquart O; Rispaud-Blanc H; Gauthier L; Rossi B; Chanteux S; Gourdin N; Amigues B; Roussel A; Bensussan A; Eliaou JF; Bastid J; Romagné F; Morel Y; Narni-Mancinelli E; Vivier E; Paturel C; Bonnefoy N
    Cell Rep; 2019 May; 27(8):2411-2425.e9. PubMed ID: 31116985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes.
    Raczkowski F; Rissiek A; Ricklefs I; Heiss K; Schumacher V; Wundenberg K; Haag F; Koch-Nolte F; Tolosa E; Mittrücker HW
    PLoS One; 2018; 13(5):e0197151. PubMed ID: 29742141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function.
    Nagate Y; Ezoe S; Fujita J; Okuzaki D; Motooka D; Ishibashi T; Ichii M; Tanimura A; Kurashige M; Morii E; Fukushima T; Suehiro Y; Yokota T; Shibayama H; Oritani K; Kanakura Y
    Leukemia; 2021 Jan; 35(1):107-118. PubMed ID: 32203145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
    Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
    Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
    Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
    FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas.
    Xu S; Shao QQ; Sun JT; Yang N; Xie Q; Wang DH; Huang QB; Huang B; Wang XY; Li XG; Qu X
    Neuro Oncol; 2013 Sep; 15(9):1160-72. PubMed ID: 23737488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the T Cell Response by CD39.
    Takenaka MC; Robson S; Quintana FJ
    Trends Immunol; 2016 Jul; 37(7):427-439. PubMed ID: 27236363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.
    Hilchey SP; Kobie JJ; Cochran MR; Secor-Socha S; Wang JC; Hyrien O; Burack WR; Mosmann TR; Quataert SA; Bernstein SH
    J Immunol; 2009 Nov; 183(10):6157-66. PubMed ID: 19864600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells regulate the distribution of natural killer T cells through CD39 signal transduction in asthma.
    Lu Y; Li Y; Zhou W; Ding B; Yu Q
    Hum Cell; 2019 Apr; 32(2):141-149. PubMed ID: 30539423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.
    Pulte D; Furman RR; Broekman MJ; Drosopoulos JH; Ballard HS; Olson KE; Kizer JR; Marcus AJ
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):367-72. PubMed ID: 21816376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells from Patients with Rheumatoid Arthritis Show Conserved CD39-Mediated Regulatory Function and increased CD39 Expression After Positive Response to Therapy.
    Zacca ER; Amezcua Vesely MC; Ferrero PV; Acosta CDV; Ponce NE; Bossio SN; Mussano E; Onetti L; Cadile I; Acosta Rodríguez EV; Montes CL; Gruppi A
    J Mol Biol; 2021 Jan; 433(1):166687. PubMed ID: 33098857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD39+ regulatory T cells attenuate allergic airway inflammation.
    Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
    Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.
    Yang R; Elsaadi S; Misund K; Abdollahi P; Vandsemb EN; Moen SH; Kusnierczyk A; Slupphaug G; Standal T; Waage A; Slørdahl TS; Rø TB; Rustad E; Sundan A; Hay C; Cooper Z; Schuller AG; Woessner R; Borodovsky A; Menu E; Børset M; Sponaas AM
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32409420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD39/adenosine pathway is involved in AIDS progression.
    Nikolova M; Carriere M; Jenabian MA; Limou S; Younas M; Kök A; Huë S; Seddiki N; Hulin A; Delaneau O; Schuitemaker H; Herbeck JT; Mullins JI; Muhtarova M; Bensussan A; Zagury JF; Lelievre JD; Lévy Y
    PLoS Pathog; 2011 Jul; 7(7):e1002110. PubMed ID: 21750674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
    Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
    FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia.
    Perry C; Hazan-Halevy I; Kay S; Cipok M; Grisaru D; Deutsch V; Polliack A; Naparstek E; Herishanu Y
    Ann Hematol; 2012 Aug; 91(8):1271-9. PubMed ID: 22349724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine.
    Bai A; Moss A; Rothweiler S; Serena Longhi M; Wu Y; Junger WG; Robson SC
    Nat Commun; 2015 Nov; 6():8819. PubMed ID: 26549640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.